JNJ

186.84

-1.13%↓

ABT

123.18

-0.32%↓

TMO

561.96

-1.07%↓

ISRG

540.64

+1.17%↑

DHR

214.37

-0.58%↓

JNJ

186.84

-1.13%↓

ABT

123.18

-0.32%↓

TMO

561.96

-1.07%↓

ISRG

540.64

+1.17%↑

DHR

214.37

-0.58%↓

JNJ

186.84

-1.13%↓

ABT

123.18

-0.32%↓

TMO

561.96

-1.07%↓

ISRG

540.64

+1.17%↑

DHR

214.37

-0.58%↓

JNJ

186.84

-1.13%↓

ABT

123.18

-0.32%↓

TMO

561.96

-1.07%↓

ISRG

540.64

+1.17%↑

DHR

214.37

-0.58%↓

JNJ

186.84

-1.13%↓

ABT

123.18

-0.32%↓

TMO

561.96

-1.07%↓

ISRG

540.64

+1.17%↑

DHR

214.37

-0.58%↓

Search

Cartesian Therapeutics Inc

Открыт

8.03 -0.37

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

7.8

Макс.

8.22

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+392.04% upside

Cartesian Therapeutics Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

2 нояб. 2025 г., 22:13 UTC

Отчет

Westpac Raises Dividend Despite 1% Slip in Annual Profit -- Update

2 нояб. 2025 г., 21:23 UTC

Отчет

Westpac Raises Dividend Despite 1% Slip in Annual Profit

2 нояб. 2025 г., 23:43 UTC

Обсуждения рынка

Gold Falls on Reports of China's Finance Ministry Ending Tax Incentive for Gold Sales -- Market Talk

2 нояб. 2025 г., 23:34 UTC

Обсуждения рынка

Oil Rises as OPEC+ Signals Output-Increase Pause -- Market Talk

2 нояб. 2025 г., 21:00 UTC

Отчет

Westpac Has Set Tech Overhaul Goals and Will Share Progress, CEO Says>WBC.AU

2 нояб. 2025 г., 21:00 UTC

Отчет

Westpac Is Now Executing on Tech Overhaul, CEO Says>WBC.AU

2 нояб. 2025 г., 21:00 UTC

Отчет

Westpac Has Completed Tech Overhaul's Discovery and Planning Phases, CEO Says >WBC.AU

2 нояб. 2025 г., 20:55 UTC

Отчет

Westpac FY Australia Mortgage Lending Up 5% on Year>WBC.AU

2 нояб. 2025 г., 20:55 UTC

Отчет

Westpac FY Institutional Lending Up 17% on Year>WBC.AU

2 нояб. 2025 г., 20:55 UTC

Отчет

Westpac FY Business Lending Up 15% on Year>WBC.AU

2 нояб. 2025 г., 20:46 UTC

Отчет

Westpac Expects Completion in 2H of FY 2026>WBC.AU

2 нояб. 2025 г., 20:46 UTC

Отчет

Westpac Expects CET1 Capital Ratio to Rise by 20 Basis Points>WBC.AU

2 нояб. 2025 г., 20:45 UTC

Отчет

Westpac: Sale Is at Slight Premium to Expected Gross Loan Value at Completion>WBC.AU

2 нояб. 2025 г., 20:44 UTC

Отчет

Westpac Selling to Consortium Including KKR, Pimco and Pepper Money>WBC.AU

2 нояб. 2025 г., 20:43 UTC

Отчет

Westpac Agrees to Sell A$21.4B Rams Mortgage Portfolio>WBC.AU

2 нояб. 2025 г., 20:42 UTC

Отчет

Westpac FY Impairment Provisions A$4.99B Vs. A$5.10B>WBC.AU

2 нояб. 2025 г., 20:41 UTC

Отчет

Westpac FY Net Profit Ex-Notable Items A$7.0B, Down 2% on Year>WBC.AU

2 нояб. 2025 г., 20:40 UTC

Отчет

Westpac FY Customer Deposits A$723.0B Vs. A$673.6B>WBC.AU

2 нояб. 2025 г., 20:39 UTC

Отчет

Westpac FY Total Loans A$851.85B Vs. A$806.77B>WBC.AU

2 нояб. 2025 г., 20:37 UTC

Отчет

Westpac FY24 Impairment Charges 5 Bps of Loans Vs. 7 Bps in FY25>WBC.AU

2 нояб. 2025 г., 20:37 UTC

Отчет

Westpac FY Operating Expenses A$11.92B Vs. A$10.94B>WBC.AU

2 нояб. 2025 г., 20:37 UTC

Отчет

Westpac FY Non-Interest Income A$3.00B Vs. A$2.835B>WBC.AU

2 нояб. 2025 г., 20:36 UTC

Отчет

Westpac FY Net Interest Income A$19.38B Vs. A$18.75B>WBC.AU

2 нояб. 2025 г., 20:35 UTC

Отчет

Westpac FY CET1 Level 2 Capital Ratio 12.5% Vs. 12.5%>WBC.AU

2 нояб. 2025 г., 20:35 UTC

Отчет

Westpac FY Net Interest Margin 1.94% Vs. 1.95%>WBC.AU

2 нояб. 2025 г., 20:35 UTC

Отчет

Westpac Raises Dividend to A$0.77 Vs. A$0.76 >WBC.AU

2 нояб. 2025 г., 20:34 UTC

Отчет

Westpac FY Rev A$22.38B Vs. A$21.59B >WBC.AU

2 нояб. 2025 г., 20:33 UTC

Отчет

Westpac FY Net A$6.92B Vs. Net A$6.99B >WBC.AU

2 нояб. 2025 г., 14:27 UTC

Отчет

Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com

2 нояб. 2025 г., 14:25 UTC

Отчет

Warren Buffett Is Leaving Berkshire Hathaway in Great Shape for His Successor After Profit Results -- Barrons.com

Сравнение c конкурентами

Изменение цены

Cartesian Therapeutics Inc Прогноз

Целевая цена

By TipRanks

392.04% рост

Прогноз на 12 месяцев

Средняя 40.2 USD  392.04%

Максимум 42 USD

Минимум 39 USD

Основано на мнении 7 аналитиков Wall Street, спрогнозировавших целевые цены для Cartesian Therapeutics Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

7 ratings

6

Покупка

1

Удержание

0

Продажа

Финансовые показатели

$

help-icon Live chat